BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21975290)

  • 1. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
    Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
    Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
    Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
    Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms.
    Choi MG; Kim SW; Han SS; Jang JY; Park YH
    Arch Surg; 2006 Jan; 141(1):51-6; discussion 56. PubMed ID: 16415411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.
    Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL
    J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development.
    Eguchi H; Ishikawa O; Ohigashi H; Tomimaru Y; Sasaki Y; Yamada T; Tsukuma H; Nakaizumi A; Imaoka S
    Surgery; 2006 Jun; 139(6):749-54. PubMed ID: 16782429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm.
    Malleo G; Marchegiani G; Borin A; Capelli P; Accordini F; Butturini G; Pederzoli P; Bassi C; Salvia R
    Ann Surg; 2015 May; 261(5):984-90. PubMed ID: 25493361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary intraductal papillary mucinous neoplasm of the pancreas.
    Denost Q; Chafai N; Arrive L; Mourra N; Paye F
    Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):e23-5. PubMed ID: 22225963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?
    Roch AM; Schneider J; Carr RA; Lancaster WP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
    J Surg Oncol; 2019 May; 119(6):777-783. PubMed ID: 30636051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
    Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
    J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas.
    Ishida M; Egawa S; Kawaguchi K; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Katayose Y; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreatology; 2008; 8(6):577-82. PubMed ID: 18824881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
    Martin ST; Matsubayashi H; Rogers CD; Philips J; Couch FJ; Brune K; Yeo CJ; Kern SE; Hruban RH; Goggins M
    Oncogene; 2005 May; 24(22):3652-6. PubMed ID: 15806175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
    Goggins M; Schutte M; Lu J; Moskaluk CA; Weinstein CL; Petersen GM; Yeo CJ; Jackson CE; Lynch HT; Hruban RH; Kern SE
    Cancer Res; 1996 Dec; 56(23):5360-4. PubMed ID: 8968085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasms of the pancreas.
    Kawakubo K; Tada M; Isayama H; Sasahira N; Nakai Y; Yamamoto K; Kogure H; Sasaki T; Hirano K; Ijichi H; Tateishi K; Yoshida H; Koike K
    Gut; 2011 Sep; 60(9):1249-53. PubMed ID: 21398676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management.
    Reid-Lombardo KM; Mathis KL; Wood CM; Harmsen WS; Sarr MG
    Ann Surg; 2010 Jan; 251(1):64-9. PubMed ID: 19858708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
    Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
    Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
    Murphy KM; Brune KA; Griffin C; Sollenberger JE; Petersen GM; Bansal R; Hruban RH; Kern SE
    Cancer Res; 2002 Jul; 62(13):3789-93. PubMed ID: 12097290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
    J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.